Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

Neurotensin subtype 1 receptors (NTS1R) represent attractive molecular targets for directing radiolabeled neurotensin (NT) analogs to tumor lesions for diagnostic and therapeutic purposes. This approach has been largely undermined by the rapid in vivo degradation of linear NT-based radioligands. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanellopoulos, Panagiotis, Kaloudi, Aikaterini, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356968/
https://www.ncbi.nlm.nih.gov/pubmed/32526874
http://dx.doi.org/10.3390/pharmaceutics12060528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356968/
https://www.ncbi.nlm.nih.gov/pubmed/32526874
http://dx.doi.org/10.3390/pharmaceutics12060528

Ejemplares similares